MedTrace Logo

Prospective Registry of Multiplex Testing (PROMPT)

NCT02665195 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 689

Last updated 2026-02-09

No results posted yet for this study

Summary

This study is being done to learn more about how changes in certain genes may be linked to cancer. Some people with cancer got their disease because they inherited an abnormal (mutated) gene.

The researchers of this study want to better understand the risks that are linked to genetic changes in these less well-studied genes. By understanding these risks, we believe that doctors will be able to give better advice to families with mutations in these genes.

Conditions

  • Genetic Testing

Interventions

OTHER

saliva specimen

BEHAVIORAL

questionnaire

Sponsors & Collaborators

Principal Investigators

  • Mark Robson, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665195 on ClinicalTrials.gov